Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa

Epidermolysis bullosa (EB) is a group of devastating genetic diseases characterized by skin and mucosal fragility and formation of blisters, which develop either spontaneously or in response to minor mechanical trauma. There is no definitive therapy for any form of EB. Intermediate junctional EB (JE...

Descripción completa

Detalles Bibliográficos
Autores principales: De Rosa, Laura, Enzo, Elena, Zardi, Giulia, Bodemer, Christine, Magnoni, Cristina, Schneider, Holm, De Luca, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440932/
https://www.ncbi.nlm.nih.gov/pubmed/34539738
http://dx.doi.org/10.3389/fgene.2021.705019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440932/
https://www.ncbi.nlm.nih.gov/pubmed/34539738
http://dx.doi.org/10.3389/fgene.2021.705019

Ejemplares similares